Studies in murine models showed that the PNPLA3 I148M sequence variation induces an increase in the lipogenic activity [24] and that downregulation of the protein is protective against NAFLD [25,26,27]. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.